A method of protecting a vascular endothelium from CD8+ cytotoxic T-lymphocyte mediated cytotoxic reactions in a subject who is about to receive or who has received an allogenic transplant and is at risk of developing or is afflicted with transplant-related complications, the method including administering to the subject human CD34-negative progenitor cells.
